Literature DB >> 8385943

SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication.

R M Snapka1, P A Permana.   

Abstract

The simian virus 40 chromosome, a model for the mammalian replicon, is a uniquely powerful system for the study of drugs and treatments which target enzymes of the mammalian replication apparatus. High resolution gel electrophoretic analysis of normal and aberrant viral replication intermediates can be used effectively to understand the molecular events of replication failure. These events include breakage of replication forks, aberrant topoisomerase action, failure to separate daughter chromosomes, protein-DNA crosslinking, single and double strand DNA breakage, alterations in topology and inactivation of replication intermediates. The SV40 replication system can also be used to study the recombinational events which often follow drug-induced replication failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385943     DOI: 10.1002/bies.950150208

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  6 in total

1.  Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.

Authors:  D Strumberg; A A Pilon; M Smith; R Hickey; L Malkas; Y Pommier
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.

Authors:  P Levac; T Moss
Journal:  Chromosoma       Date:  1996-10       Impact factor: 4.316

3.  CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage.

Authors:  R J Reid; P Fiorani; M Sugawara; M A Bjornsti
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 4.  Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes.

Authors:  N Osheroff; A H Corbett; S H Elsea; M Westergaard
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.

Authors:  C J Lukonis; J Burkham; S K Weller
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model.

Authors:  Viktor Kettmann; Daniela Kost'álová; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.